{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:10:09Z","timestamp":1776748209414,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bmc.2023.117530","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:19:48Z","timestamp":1699575588000},"page":"117530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I"],"prefix":"10.1016","volume":"96","author":[{"given":"Guiying","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117530_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.03.073","article-title":"Synthesis and identification of quinoline derivatives as topoisomerase I inhibitors with potent antipsoriasis activity in an animal model","volume":"88","author":"Zhang","year":"2019","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2018.02.058","article-title":"Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity","volume":"149","author":"Alonso","year":"2018","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0015","doi-asserted-by":"crossref","unstructured":"L.H. Meng, Z.Y. Liao, Y. Pommier Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy. Current Topics in Medicinal Chemistry 3 (2003) 305-320.","DOI":"10.2174\/1568026033452546"},{"key":"10.1016\/j.bmc.2023.117530_b0020","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/cr900097c","article-title":"DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition","volume":"109","author":"Pommier","year":"2009","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.bmc.2023.117530_b0025","first-page":"5938","article-title":"Camptothecin Resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells","volume":"59","author":"Brangi","year":"1999","journal-title":"Cancer Research"},{"key":"10.1016\/j.bmc.2023.117530_b0030","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1021\/ol026454d","article-title":"Synthetic approach to hypoxyxylerone, novel inhibitor of topoisomerase I","volume":"4","author":"Piettre","year":"2002","journal-title":"Organic Letters"},{"key":"10.1016\/j.bmc.2023.117530_b0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0960-894X(00)00596-5","article-title":"Antimitotic and cell growth inhibitory properties of combretastatin A-4 like ethers","volume":"11","author":"Lawrence","year":"2001","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.bmc.2023.117530_b0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/jm049622b","article-title":"Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines","volume":"48","author":"Simoni","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0045","doi-asserted-by":"crossref","first-page":"98527","DOI":"10.1039\/C5RA19270F","article-title":"Synthesis, biological evaluation and mechanism study of a class of cyclic combretastatin A-4 analogues as novel antitumour agents","volume":"5","author":"Yan","year":"2015","journal-title":"RSC Advances"},{"key":"10.1016\/j.bmc.2023.117530_b0050","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.1361684","article-title":"NO news is good news","volume":"258","author":"Culotta","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117530_b0055","first-page":"714","article-title":"The relationship between inducible nitric oxide synthase nitric oxide and tumor, Cancer Res","volume":"31","author":"Gao","year":"2019","journal-title":"Clinic."},{"key":"10.1016\/j.bmc.2023.117530_b0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.niox.2008.04.018","article-title":"Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases","volume":"19","author":"Bonavida","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bmc.2023.117530_b0065","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric oxide donor-based cancer therapy: Advances and prospects","volume":"60","author":"Huang","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/fso.15.44","article-title":"Nitric oxide for cancer therapy","volume":"1","author":"Huerta","year":"2015","journal-title":"Future Science OA"},{"key":"10.1016\/j.bmc.2023.117530_b0075","first-page":"663","article-title":"Advances in the research on the antitumor effect of nitric oxide as a body drug","volume":"39","author":"Bin","year":"2019","journal-title":"Journal of Traditional Chinese Medicine University of Hunan."},{"key":"10.1016\/j.bmc.2023.117530_b0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1875-5364(12)60089-2","article-title":"Synthesis of novel furozan-based nitric oxide-releasing derivatives of 1-oxo-oridonin with anti-proliferative activity","volume":"10","author":"Li","year":"2012","journal-title":"Chin J Nat Medicines."},{"key":"10.1016\/j.bmc.2023.117530_b0085","first-page":"293","article-title":"Synthesis and antitumor activity of nitric oxide donor CDDO analogues","volume":"43","author":"Zhang","year":"2012","journal-title":"J Chin Pharm Univ."},{"key":"10.1016\/j.bmc.2023.117530_b0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cbdd.13120","article-title":"Design, synthesis, and cytotoxic evaluation of novel scopoletin derivatives","volume":"91","author":"Shi","year":"2017","journal-title":"Chemical Biology & Drug Design"},{"key":"10.1016\/j.bmc.2023.117530_b0095","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1021\/acs.jmedchem.7b01862","article-title":"Design, synthesis, and biological evaluation of 4-quinoline carboxylic acids as inhibitors of dihydroorotate dehydrogenase","volume":"61","author":"Madak","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0100","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1021\/jm400463q","article-title":"Novel hybrids of (phenyl sulfonyl) furoxan and anilino pyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer","volume":"56","author":"Han","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0105","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/jm049146p","article-title":"Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex","volume":"48","author":"Staker","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.bmc.2023.117530_b0115","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1039\/D0NJ02941F","article-title":"Improved antiproliferative activity of novel Pulsatilla saponin D\/\u03b1-hederin derivatives containing nitric oxide donors","volume":"44","author":"Yang","year":"2020","journal-title":"New Journal of Chemistry"},{"key":"10.1016\/j.bmc.2023.117530_b0120","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/1078-0432.CCR-0914-3","article-title":"VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein","volume":"10","author":"Minderman","year":"2004","journal-title":"Clinical Cancer Research"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:31Z","timestamp":1760837071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":24,"alternative-id":["S0968089623003784"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117530","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117530"}}